Main Products
GM-XANTHO • Non-steroidal topical new drug for treating atopic dermatitis • Effective in treating and preventing inflammatory skin conditions • Currently in Phase 2a clinical study for atopic dermatitis • Low side effects • Available in large quantities with PIC/S GMP specification
Business Interests
ut-Licensing GM-XANTHO is available for out-licensing with rights in drug development and commercialization.
Contact Info
William Wu
Head of Business Development
+886-2-2655-7790
william@xanthobio.com